Japan Animal Referral Medical Center Co.,Ltd. (6039.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	6.0B	6.2B	5.3B	4.3B	3.9B
Cost of Revenue	910.4M	3.7B	3.4B	2.8B	2.4B
Gross Profit	563.0M	2.5B	1.8B	1.5B	1.4B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	304.3M	1.4B	1.1B	967.4M	862.4M
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	304.3M	1.4B	1.1B	967.4M	862.4M
Cost and Expenses	4.9B	5.0B	4.6B	3.8B	3.3B
Operating Income (EBIT)	1.1B	1.1B	720.0M	496.0M	580.0M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	8.8M	36.1M	26.0M	18.8M	17.6M
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	(687.0K)	(8.2M)	(729.0K)	(7.1M)	(46.5M)
Non-Operating Income (excl Interest)	2.0M	8.4M	7.1M	9.0M	6.6M
EBT (Pre-Tax Income)	258.1M	1.1B	720.3M	491.3M	533.9M
Income Tax Expense	77.8M	308.6M	199.3M	154.1M	153.3M
Bottom Line
Net Income	786.0M	833.0M	520.0M	337.0M	380.0M
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	786.0M	833.0M	520.0M	337.0M	380.0M
Per Share
Basic EPS	¥223	¥64	¥201	¥123	¥156
Diluted EPS	¥223	¥64	¥201	¥121	¥153
Revenue Per Share	¥464	¥479	¥2,037	¥1,558	¥1,590
Shares
Basic Shares Outstanding	12.9M	12.9M	2.6M	2.7M	2.4M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	1.7B	1.3B	940.1M	971.5M
D&A	—	568.3M	550.3M	444.1M	391.5M
EBIT	1.1B	1.1B	720.0M	496.0M	580.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026